ReviewCureus2023
Gender Equality Trends of First Authors in Publications of Artificial Intelligence and Thyroid.
Review in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thyroid diseases are diverse, ranging from benign conditions to potentially life-threatening disorders. Recently, the application of artificial intelligence (AI) in evaluating thyroid disease has significantly enhanced medical research, diagnosis prediction, and algorithm development. Coupled with this advancement is the rising focus on the importance of gender equality in scientific publications. This study delves into the gender trends of first authors in papers related to "Artificial Intelligence and Thyroid" sourced from PubMed from 2003 to 2022, scrutinizing these trends based on both country and year. A bibliometric analysis was conducted on PubMed to retrieve relevant articles over this 19-year time span. Following this, the names and affiliated countries of the first authors were determined. The Namsor app, a tool for classifying personal names by gender, origin, or ethnicity, was then used to segregate the data based on gender. Statistical analyses were performed using the R software- ARIMA model and Fisher's exact test was applied to examine the correlations between gender and country of origin. From the 254 analyzed articles, 43.5% of the first authors were female, while 56.69% were male. The year 2022 saw the most significant number of female first-author publications. Intriguingly, the European Journal of Radiology was prominent due to its favorable gender ratio. Moreover, the association between gender and country was significant, with China being a standout. Limitations included focusing only on PubMed journals and using a third party for gender identification. Nevertheless, the study reveals a move toward gender parity in AI and thyroid research over the past 18 years, emphasizing the importance of sustained efforts for academic inclusivity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.